Physician profile
Jerilyn Marie Wright
NPI 1437802717
$1,079.76
in general payments reported to CMS, 2019-2025
13 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $152 · 2024: $329 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $935.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $377.43 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $163.13 | 2023-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $136.83 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $81.40 | 2022-2023 | Rybelsus, Ozempic |
| Pfizer INC. | $68.30 | 2022-2025 | |
| Lilly USA, LLC | $65.00 | 2023-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $44.46 | 2024-2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $36.16 | 2024-2025 | Veozah |
| Lundbeck LLC | $26.31 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $25.12 | 2024 | Qelbree |
| Dexcom, INC. | $23.28 | 2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $17.05 | 2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.29 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerilyn Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.